You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Medtronic
Johnson and Johnson
Merck
McKesson

Last Updated: March 3, 2021

DrugPatentWatch Database Preview

Litigation Details for IN RE: Entresto (Sacubitril/Valsartan) Patent Litigation (J.P.M.L. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in IN RE: Entresto (Sacubitril/Valsartan) Patent Litigation
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for IN RE: Entresto (Sacubitril/Valsartan) Patent Litigation (J.P.M.L. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-12-19 1 Memorandum where a patent 4 Plaintiff has asserted U.S. Patent Nos. 8,877,938 and 9,388,134 (“’938 patent” and …and “’134 patent,” respectively) against all defendants. Plaintiff also has asserted U.S. Patent No. 8,101,6598,101,659 (“’659 patent”) against all defendants except Alembic, Lupin, and Noratech and U.S. Patent No. 8,796,331…’331 patent”) against all Defendants except Alembic, Lupin, Macleods, and Noratech. These patents are …underlying the patents, prior art, claim construction and issues of infringement involving the patents.” In re External link to document
2020-03-27 78 The patents are U.S. Patents Nos. 8,101,659 (the ’659 patent), 8,796,331 (the ’331 patent), 8,877,…8,877,938 (the ’938 patent), and 9,388,134 (the ’134 patent). Plaintiff alleges that all defendants in all… and ’134 patents, and that most of the defendants also infringed the ’659 and ’331 patents. … MDL No. 2930 PATENT LITIGATION …actions on the motion are a series of Hatch-Waxman3 patent infringement lawsuits, in which Novartis alleges External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Medtronic
Express Scripts
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.